Vaccine News and Research

Latest Vaccine News and Research

Yellow fever outbreak in Sudan's Darfur kills 67, WHO reports

"A yellow fever outbreak in Sudan's Darfur region has killed 67 people so far," and "the number of cases has more than doubled since the start of the epidemic last month," the WHO said in a statement on Wednesday, the U.N. News Centre reports.

9 Nov 2012

Immunomic Therapeutics initiates JRC-LAMP-vax vaccine Phase I trial in Sugi allergy

Immunomic Therapeutics, Inc., a leader in developing novel allergy immunotherapies, announced today that it has dosed the first patient in a Phase I clinical trial of its lead candidate, JRC-LAMP-vax vaccine, at its clinical site in Honolulu, Hawaii. Initial subjects include Japanese ex-patriates previously exposed to Japanese red cedar, or "Sugi," as it is known in Japan.

9 Nov 2012

Soligenix receives FDA Fast Track designation for SGX203 to treat pediatric Crohn's disease

Soligenix, Inc., a development stage biopharmaceutical company, announced today that its program for development of SGX203 (oral beclomethasone 17,21-dipropionate or oral BDP) for the induction treatment of mild-to-moderate pediatric Crohn's disease has received "Fast Track" designation from the U.S. Food and Drug Administration (FDA).

8 Nov 2012

Pevion launches Defensomes platform for broad spectrum immune enhancement

Pevion Biotech AG today announced the launch of a new program called Defensomes, a platform for broad spectrum immune enhancement via mechanisms of innate immunity. The proprietary technology is derived from a vaccine platform with a solid safety track record comprising more than 80 million doses applied to humans to date. Defensomes offer opportunities for a wide range of prophylactic and therapeutic indications, where boosting of the body's own natural defense is beneficial.

8 Nov 2012

Patient recruitment complete for immatics IMA901 Phase 3 trial for renal cell carcinoma

immatics biotechnologies GmbH, a biopharmaceutical company developing rationally designed therapeutic vaccines that are active against cancer, announced today that it has completed patient recruitment into the pivotal phase 3 trial evaluating its lead cancer vaccine IMA901 for renal cell carcinoma (RCC). The trial has completed patient inclusion and it is expected that around 345 patients will be randomized across 10 countries in the US and Europe.

8 Nov 2012

Two new EU Member States now represented within TRANSVAC services platform

In addition to the initial panel of nine services, the TRANSVAC transnational access platform has integrated in July 2012 five additional groups which provide their services to users on a free and paid basis. Two new European Union (EU) Member States are now represented within the platform of services: France and Portugal.

8 Nov 2012

London School of Hygiene & Tropical Medicine creates International Diagnostics Centre

Today sees the launch of the International Diagnostics Centre (IDC), a global research collaboration hub, created at the London School of Hygiene & Tropical Medicine to undertake innovative research on the development and deployment of new diagnostic tests that enable patients to be diagnosed faster, more accurately and cost effectively.

8 Nov 2012

Texas Biomed develops rapid, less expensive route to screen suitable tests for bioterror threats

Texas Biomedical Research Institute scientists in San Antonio have developed a faster, less expensive route to screen suitable tests for bioterror threats and accelerate the application of countermeasures.

7 Nov 2012

WHO survey shows low knowledge level, acceptance of polio vaccine among Pashtun Pakistanis

"Polio will never be eradicated in Pakistan until a way is found to persuade poor Pashtuns to embrace the vaccine, according to a study released by the World Health Organization" in its November bulletin, the New York Times reports.

7 Nov 2012

Loyola announces 2012 Junior and Senior Scientist of the Year during St. Albert's Day

Katherine L. Knight, PhD, one of the nation's leading immune system researchers, has been named 2012 Senior Scientist of the Year at Loyola University Chicago Stritch School of Medicine. Sakthivel Sadayappan, PhD, FAHA, who is doing groundbreaking research on a protein that is critical for the normal functioning of the heart, has been named 2012 Junior Scientist of the Year.

7 Nov 2012

Sabin initiates Part II of Na-GST-1 vaccine Phase I hookworm trial

The Sabin Vaccine Institute (Sabin) today announced the start of Part II of its Phase I clinical trial of the Na-GST-1 vaccine candidate, marking another major milestone in the progress toward developing a human hookworm vaccine.

6 Nov 2012

Alnylam third quarter 2012 revenues decrease to $16.8 million

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, today reported its consolidated financial results for the third quarter 2012, and company highlights.

6 Nov 2012

PsiOxus receives UK government grant to initiate ColoAd1 Phase I/II trial for ovarian cancer

PsiOxus Therapeutics, Ltd., a development stage biotechnology company, today announced the award of a £1.7 million ($2.7 million) grant from the UK government-backed Biomedical Catalyst to initiate a Phase I/II clinical trial to assess the use of ColoAd1 in the treatment of platinum-resistant, recurrent ovarian cancer.

5 Nov 2012

WHO reports on global diphtheria-tetanus-pertussis vaccination efforts

"Four in five children (83 percent) worldwide received the recommended three doses of diphtheria-tetanus-pertussis (DTP) vaccine during infancy in 2011, according to new data released in the Morbidity and Mortality Weekly Report and in the WHO Weekly Epidemiological Record (WER)," a WHO media note reports.

3 Nov 2012

Blog reports on meeting of world's largest HIV vaccine research network

KPLU 88.5's "Humanosphere" blog reports on a meeting of the HIV Vaccine Trials Network (HVTN), "the world's largest HIV vaccine research network," held in Seattle this week. "We actually don't know what the agenda is," HVTN Executive Director Jim Kublin said during a lecture, titled "Scientific Agenda, the Next Seven Years," according to the blog.

3 Nov 2012

Two research groups present data on Pressure BioSciences' PCT Platform at HUPO 2012

Pressure BioSciences, Inc. today announced that scientists from two separate research groups presented data at the recent HUPO 11th Annual World Congress (Boston, MA) indicating that the incorporation of the Company's Pressure Cycling Technology Platform into their sample preparation processes resulted in a marked improvement in the quality and/or efficiency of test results.

3 Nov 2012

Bristol-Myers Squibb welcomes decision by NICE to recommend Yervoy for advanced melanoma

Today, Bristol-Myers Squibb is pleased to welcome the decision by The National Institute for Health and Clinical Excellence (NICE) to recommend Yervoy (ipilimumab) for the treatment of previously-treated advanced (unresectable or metastatic) melanoma within the Final Appraisal Determination (FAD).

3 Nov 2012

'Details of implementation' critical to reaching goal of AIDS-free generation

Noting the progress made since the beginning of the HIV/AIDS epidemic and the upcoming recognition of World AIDS Day on December 1, Ronald Valdiserri, deputy assistant secretary for health, infectious diseases at the Department of Health and Human Services, writes in a Public Health Reports opinion piece, "We would do well to keep in mind the following caution. No matter the elegance of the controlled trial, the statistical significance of the results, or the superiority of the science, we must confront this inevitable reality: We will never be able to take full advantage of our progress in HIV clinical and prevention science until we develop and sustain the human, organizational, and structural capacities necessary to implement these new scientific breakthroughs."

3 Nov 2012

Pregnant women in rural Ghana are now getting health information via mobile phone

Pregnant women in rural Ghana are now getting health information via mobile phone. The pilot project is part of an international initiative to employ mobile technology to improve the health of people in developing countries.

3 Nov 2012

MH6 vaccine shows promise in treating meth addiction

Scientists at The Scripps Research Institute (TSRI) have performed successful tests of an experimental methamphetamine vaccine on rats. Vaccinated animals that received the drug were largely protected from typical signs of meth intoxication.

2 Nov 2012

Vaccine News and Research

Latest Vaccine News and Research

Yellow fever outbreak in Sudan's Darfur kills 67, WHO reports

Immunomic Therapeutics initiates JRC-LAMP-vax vaccine Phase I trial in Sugi allergy

Soligenix receives FDA Fast Track designation for SGX203 to treat pediatric Crohn's disease

Pevion launches Defensomes platform for broad spectrum immune enhancement

Patient recruitment complete for immatics IMA901 Phase 3 trial for renal cell carcinoma

Two new EU Member States now represented within TRANSVAC services platform

London School of Hygiene & Tropical Medicine creates International Diagnostics Centre

Texas Biomed develops rapid, less expensive route to screen suitable tests for bioterror threats

WHO survey shows low knowledge level, acceptance of polio vaccine among Pashtun Pakistanis

Loyola announces 2012 Junior and Senior Scientist of the Year during St. Albert's Day

Sabin initiates Part II of Na-GST-1 vaccine Phase I hookworm trial

Alnylam third quarter 2012 revenues decrease to $16.8 million

PsiOxus receives UK government grant to initiate ColoAd1 Phase I/II trial for ovarian cancer

WHO reports on global diphtheria-tetanus-pertussis vaccination efforts

Blog reports on meeting of world's largest HIV vaccine research network

Two research groups present data on Pressure BioSciences' PCT Platform at HUPO 2012

Bristol-Myers Squibb welcomes decision by NICE to recommend Yervoy for advanced melanoma

'Details of implementation' critical to reaching goal of AIDS-free generation

Pregnant women in rural Ghana are now getting health information via mobile phone

MH6 vaccine shows promise in treating meth addiction

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Newsletters you may be interested in